Orthofix Medical Inc. Finance Lease, Right-of-Use Asset, Amortization
Orthofix Medical Inc. (OFIX) reported Finance Lease, Right-of-Use Asset, Amortization of $1.01 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-24
- Orthofix Medical Inc. finance lease, right-of-use asset, amortization for the quarter ending 2019-12-31 was $244.00K.
- Orthofix Medical Inc. finance lease, right-of-use asset, amortization for the quarter ending 2019-09-30 was $244.00K.
- Orthofix Medical Inc. finance lease, right-of-use asset, amortization for the quarter ending 2019-06-30 was $245.00K.
- Orthofix Medical Inc. finance lease, right-of-use asset, amortization for the quarter ending 2019-03-31 was $239.00K.
- Orthofix Medical Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $1.01M, a 0.00% change from fiscal 2024.
- Orthofix Medical Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $1.01M, a 0.10% increase from fiscal 2023.
- Orthofix Medical Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $1.01M, a 18.17% decline from fiscal 2022.
- Orthofix Medical Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $1.24M, a 39.58% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.01M 10-K · filed 2026-02-24 | |||
| 2024-12-31 | $1.01M 10-K · filed 2026-02-24 | |||
| 2023-12-31 | $1.01M 10-K · filed 2026-02-24 | |||
| 2022-12-31 | $1.24M 10-K · filed 2025-02-25 | |||
| 2021-12-31 | $2.05M 10-K · filed 2024-03-05 | |||
| 2020-12-31 | $1.77M 10-K · filed 2023-03-06 | |||
| 2019-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $488.00K derived: sum of 2 quarters · filed 2022-02-25 | $733.00K derived: sum of 3 quarters · filed 2022-02-25 | $972.00K 10-K · filed 2022-02-25 |
| 2019-09-30 | $244.00K 10-Q · filed 2019-10-28 | $489.00K derived: sum of 2 quarters · filed 2019-10-28 | $728.00K 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $245.00K 10-Q · filed 2019-08-05 | $484.00K 10-Q · filed 2019-08-05 | ||
| 2019-03-31 | $239.00K 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |